USANA Health Sciences Inc. reported fiscal 2025 net sales of USD 16 million, reflecting an 8% increase driven primarily by a full-year contribution from Hiya. Core nutritional business net sales declined 8% due to a challenging customer acquisition environment in key markets. Net earnings attributable to shareholders for the period were USD 11 million. Adjusted diluted earnings per share stood at USD 0.60. The company highlighted ongoing execution of its diversification strategy toward an omnichannel model, with net sales outside of the core nutritional business representing 16% of consolidated net sales. Rise Wellness saw strong momentum, with sales tripling as distribution expanded into key retail outlets and the launch of Protein Pop at a large club retailer in the first quarter.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202602171615BIZWIRE_USPR_____20260217_BW081610) on February 17, 2026, and is solely responsible for the information contained therein.